<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">347734</id>
  <title nil="true"/>
  <common-name>5-hydroxy-4-[(z)-indol-3-ylidenemethyl]-2-methyl-n-[(e)-n-(2-methylanilino)-c-phenylcarbonimidoyl]iminoimidazole-1-carbothioamide</common-name>
  <description>5-hydroxy-4-[(z)-indol-3-ylidenemethyl]-2-methyl-n-[(e)-n-(2-methylanilino)-c-phenylcarbonimidoyl]iminoimidazole-1-carbothioamide is a chemical compound with the formula C28H23N7OS. With an average molecular weight of 505.60 g/mol, 5-hydroxy-4-[(z)-indol-3-ylidenemethyl]-2-methyl-n-[(e)-n-(2-methylanilino)-c-phenylcarbonimidoyl]iminoimidazole-1-carbothioamide is a heavy molecule.</description>
  <cas>109901-86-2</cas>
  <pubchem-id>135599723</pubchem-id>
  <chemical-formula>C28H23N7OS</chemical-formula>
  <weight>505.6</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T11:32:32Z</created-at>
  <updated-at type="dateTime">2026-08-31T11:32:32Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC1=CC=CC=C1NN=C(C2=CC=CC=C2)N=NC(=S)N3C(=NC(=C3O)C=C4C=NC5=CC=CC=C54)C</moldb-smiles>
  <moldb-formula>C28H23N7OS</moldb-formula>
  <moldb-inchi>InChI=1S/C28H23N7OS/c1-18-10-6-8-14-23(18)31-32-26(20-11-4-3-5-12-20)33-34-28(37)35-19(2)30-25(27(35)36)16-21-17-29-24-15-9-7-13-22(21)24/h3-17,31,36H,1-2H3/b21-16+,32-26+,34-33?</moldb-inchi>
  <moldb-inchikey>QQBGPBASIGIHQS-VMDSNOKNSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">505.1684796</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>6.8</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM343627</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>5-hydroxy-4-[(z)-indol-3-ylidenemethyl]-2-methyl-n-[(e)-n-(2-methylanilino)-c-phenylcarbonimidoyl]iminoimidazole-1-carbothioamide</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom nil="true"/>
  <superklass nil="true"/>
  <klass nil="true"/>
  <subklass nil="true"/>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0298072</sync-id>
  <structure-inchikey>QQBGPBASIGIHQS-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>20000000400200000000000000000000200000040080000000000040000000004000000080000020040000000000008000000000000000080440010000800000010800000000000000002000000002080000040000000000000000000100200000010000000000000000040001008000000000800000000000000000400000008000000008000020800000000001000000804000000000002000000000000000000000000841000000000004000000000000000008a0000020000000020000002000000000000000000000008000002000000200000010000000000000000005004040000000001000000000000000004001000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAlAAAAKQAAAIABBgBgAAAAAQMGQCgAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:46:18Z</structure-indexed-at>
</compound>
